N. Anitha
Bharath University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by N. Anitha.
Journal of Pharmacy and Bioallied Sciences | 2015
N. Anitha; SLeena Sankari; L. Malathi; R. Karthick
Fibrous dysplasia (FD) is a benign intramedullary fibro-osseous lesion. FD is a bone developmental anomaly characterized by replacement of normal bone and marrow bone by fibrous tissue. It involves any of the bones as single lesion (monostotic) or in multiple bone lesions (polyostotic) or all of the skeletal system (panostotic). Long bones are most commonly involved, which mostly identified incidentally and clinically appears asymptomatic. Clinical, radiographical and histopathological findings will help in confirming the lesion. There are many treatment option available, but still management of FD remains challenging.
Journal of Pharmacy and Bioallied Sciences | 2015
L. Malathi; R Amsaveni; N. Anitha; N. Balachander
The mononuclear phagocyte system consists of cells that have a common lineage whose primary function is phagocytosis. The specific immunity is achieved by the combined effects of macrophages and lymphocytes, and system has been called lymphoreticular system. Reticuloendothelial system means a special group of cells, scattered in different parts of the body, but all having some common characteristics. These cells are powerful phagocytes.
Journal of Pharmacy and Bioallied Sciences | 2015
N. Anitha; Sudha Jimson; K. M. K. Masthan; Jenita Jacobina
Oral squamous cell carcinoma (OSCC) is ranking 1st among males and 4th among females in India. In spite of major advances in diagnosis and treatment of OSCC, survival rates, have remained poor. Circulating tumor cells (CTCs) in the blood stream, play an important role in establishing metastases. It is important to identify patients suffering from nonlocalized tumor with “circulating” tumor cells to determine the tailor made, systemic therapy in addition to local resection and irradiation. Thus, detecting metastases at an early stage are needed for better prognosis and survival. CTCs as new prognostic marker to detect the metastatic potential will provide a novel insight into tumor burden and efficacy of therapy. The recent advances and its application in OSCC will be reviewed.
Journal of Pharmacy and Bioallied Sciences | 2015
N. Aravindha Babu; S. Leena Sankari; N. Anitha; Gouse Mohideen
Granular cell ameloblastoma is a slow growing odontogenic ectodermal tumor. The tumor shows typical ameloblastoma with the cells showing eosinophilic granularity. This variant of ameloblastoma is aggressive with high recurrence rates. We report a case of aggressive ameloblastoma of granular cell variant
Biomedical and Pharmacology Journal | 2015
Karthick; K. M. K. Masthan; N. Aravindha Babu; R. Jayasri Krupaa; N. Anitha
Archive | 2014
Vidhya Rani; S. Leena; N. Aravindha Babu; N. Anitha; Sudha Manikkam; Sree Balaji
Archive | 2014
Rajesh E; Masthan Kmk; Aravindha Babu N; Balachander N; N. Anitha; Jayasri Krupaa R
Biomedical and Pharmacology Journal | 2016
M. K. Masthan; E. Rajesh; U. Tamilarasi; N. Anitha
Biomedical and Pharmacology Journal | 2016
M. K. Masthan; N. Anitha; Jenita Jacobina; N. Aravindha Babu
Biomedical and Pharmacology Journal | 2016
Aravindha Babu; N. Anitha; U. Tamilarasi; S. Leena Sankari